» Articles » PMID: 29152157

A Dysbiotic Mycobiome Dominated by is Identified Within Oral Squamous-cell Carcinomas

Overview
Specialty Dentistry
Date 2017 Nov 21
PMID 29152157
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to characterize the mycobiome associated with oral squamous-cell carcinoma (OSCC). DNA was extracted from 52 tissue biopsies (cases: 25 OSCC; controls: 27 intra-oral fibro-epithelial polyps [FEP]) and sequenced for the fungal internal transcribed spacer 2 region using Illumina™ 2 x300bp chemistry. Merged reads were classified to species level using a BLASTN-algorithm with UNITE's named species sequences as reference. Downstream analyses were performed using QIIME™ and linear discriminant analysis effect size. A total of 364 species representing 160 genera and two phyla (Ascomycota and Basidiomycota) were identified, with  and  making up 48% and 11% of the average mycobiome, respectively. However, only five species and four genera were detected in ≥50% of the samples. The species richness and diversity were significantly lower in OSCC. Genera , , and  were overrepresented in OSCC;  and   were more abundant in FEP. Species-wise, , , and a -like species were enriched in OSCC, while -like species, , and were the most significantly abundant in FEP. In conclusion, a dysbiotic mycobiome dominated by  was found in association with OSCC, a finding worth further investigation.

Citing Articles

The Global Trends and Advances in Oral Microbiome Research on Oral Squamous Cell Carcinoma: A Systematic Review.

Dumitrescu R, Bolchis V, Fratila A, Jumanca D, Buzatu B, Sava-Rosianu R Microorganisms. 2025; 13(2).

PMID: 40005740 PMC: 11858510. DOI: 10.3390/microorganisms13020373.


The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.

Ding T, Liu C, Li Z Mol Cancer. 2025; 24(1):18.

PMID: 39815314 PMC: 11734361. DOI: 10.1186/s12943-025-02227-8.


Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site.

Dorobisz K, Dorobisz T, Pazdro-Zastawny K Cancers (Basel). 2024; 16(19).

PMID: 39410035 PMC: 11475148. DOI: 10.3390/cancers16193416.


The role of the microbiome in head and neck squamous cell cancers.

Sahin T, Sonmezer M Eur Arch Otorhinolaryngol. 2024; 282(2):623-637.

PMID: 39306588 DOI: 10.1007/s00405-024-08966-6.


"Nutrient-fungi-host" tripartite interaction in cancer progression.

Wu D, Guan Y, Li C, Zheng Q, Yin Z, Wang H Imeta. 2024; 3(2):e170.

PMID: 38882486 PMC: 11170973. DOI: 10.1002/imt2.170.


References
1.
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett W . Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 12(6):R60. PMC: 3218848. DOI: 10.1186/gb-2011-12-6-r60. View

2.
Gokul Raj K, Sambantham S, Manikanadan R, Arulvasu C, Pandi M . Fungal taxol extracted from Cladosporium oxysporum induces apoptosis in T47D human breast cancer cell line. Asian Pac J Cancer Prev. 2014; 15(16):6627-32. DOI: 10.7314/apjcp.2014.15.16.6627. View

3.
Baker J, Bor B, Agnello M, Shi W, He X . Ecology of the Oral Microbiome: Beyond Bacteria. Trends Microbiol. 2017; 25(5):362-374. PMC: 5687246. DOI: 10.1016/j.tim.2016.12.012. View

4.
Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

5.
Dupuy A, David M, Li L, Heider T, Peterson J, Montano E . Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS One. 2014; 9(3):e90899. PMC: 3948697. DOI: 10.1371/journal.pone.0090899. View